Alaunos Therapeutics (TCRT) Revenue & Revenue Breakdown
Alaunos Therapeutics Revenue Highlights
Latest Revenue (Y)
$5.00K
Latest Revenue (Q)
$4.00K
Alaunos Therapeutics Revenue by Period
Alaunos Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $5.00K | -99.83% |
| 2022-12-31 | $2.92M | 634.17% |
| 2021-12-31 | $398.00K | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | -100.00% |
| 2018-12-31 | $146.00K | -97.71% |
| 2017-12-31 | $6.39M | -6.88% |
| 2016-12-31 | $6.86M | 58.38% |
| 2015-12-31 | $4.33M | 215.51% |
| 2014-12-31 | $1.37M | 71.63% |
| 2013-12-31 | $800.00K | - |
| 2012-12-31 | $800.00K | 19.94% |
| 2011-12-31 | $667.00K | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2007-12-31 | - | 100.00% |
| 2006-12-31 | - | 100.00% |
| 2005-12-31 | - | 100.00% |
| 2004-12-31 | - | 100.00% |
| 2003-12-31 | - | -100.00% |
| 2002-12-31 | $2.57K | 48.90% |
| 2001-12-31 | $1.73K | - |
Alaunos Therapeutics generated $5.00K in revenue during NA 2023, up -99.83% compared to the previous quarter, and up 3.42% compared to the same period a year ago.
Alaunos Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $4.00K | 300.00% |
| 2024-03-31 | $1.00K | - |
| 2023-12-31 | $1.00K | 100.00% |
| 2023-09-30 | - | -100.00% |
| 2023-06-30 | $4.00K | 100.00% |
| 2023-03-31 | - | -100.00% |
| 2022-12-31 | $11.00K | -99.62% |
| 2022-09-30 | $2.91M | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2021-09-30 | $398.00K | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | -100.00% |
| 2018-03-31 | $146.00K | -90.86% |
| 2017-12-31 | $1.60M | -0.06% |
| 2017-09-30 | $1.60M | 0.06% |
| 2017-06-30 | $1.60M | - |
| 2017-03-31 | $1.60M | - |
| 2016-12-31 | $1.60M | -0.06% |
| 2016-09-30 | $1.60M | -5.83% |
| 2016-06-30 | $1.70M | -13.81% |
| 2016-03-31 | $1.97M | 2.61% |
| 2015-12-31 | $1.92M | 2.68% |
| 2015-09-30 | $1.87M | 587.13% |
| 2015-06-30 | $272.00K | - |
| 2015-03-31 | $272.00K | -20.00% |
| 2014-12-31 | $340.00K | -46.29% |
| 2014-09-30 | $633.00K | 216.50% |
| 2014-06-30 | $200.00K | - |
| 2014-03-31 | $200.00K | - |
| 2013-12-31 | $200.00K | - |
| 2013-09-30 | $200.00K | - |
| 2013-06-30 | $200.00K | - |
| 2013-03-31 | $200.00K | - |
| 2012-12-31 | $200.00K | - |
| 2012-09-30 | $200.00K | - |
| 2012-06-30 | $200.00K | - |
| 2012-03-31 | $200.00K | - |
| 2011-12-31 | $200.00K | - |
| 2011-09-30 | $200.00K | - |
| 2011-06-30 | $200.00K | 198.51% |
| 2011-03-31 | $67.00K | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | 100.00% |
| 2008-03-31 | - | 100.00% |
| 2007-12-31 | - | - |
Alaunos Therapeutics generated $4.00K in revenue during Q2 2024, up 300.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Alaunos Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| RIGL | Rigel Pharmaceuticals | $116.88M | $36.84M |
| ADAP | Adaptimmune Therapeutics | $60.28M | $128.37M |
| PIRS | Pieris Pharmaceuticals | $42.81M | - |
| MRSN | Mersana Therapeutics | $36.85M | $2.29M |
| FENC | Fennec Pharmaceuticals | $21.64M | $25.26M |
| STOK | Stoke Therapeutics | $8.78M | $4.22M |
| CUE | Cue Biopharma | $5.49M | $1.72M |
| VRCA | Verrica Pharmaceuticals | $5.12M | $3.83M |
| FIXX | Q32 Bio | $1.16M | - |
| CKPT | Checkpoint Therapeutics | $103.00K | $41.00K |
| TCRT | Alaunos Therapeutics | $5.00K | $4.00K |
| LIAN | LianBio | - | - |
| BDTX | Black Diamond Therapeutics | - | - |
| INKT | MiNK Therapeutics | - | - |
| MDNA | Medicenna Therapeutics | - | - |
| ACHL | Achilles Therapeutics | - | - |
| LRMR | Larimar Therapeutics | - | - |
TCRT Revenue FAQ
What is Alaunos Therapeutics’s yearly revenue?
Alaunos Therapeutics's yearly revenue for 2023 was $5K, representing a decrease of -99.83% compared to 2022. The company's yearly revenue for 2022 was $2.92M, representing an increase of 634.17% compared to 2021. TCRT's yearly revenue for 2021 was $398K, representing an increase of 100.00% compared to 2020.
What is Alaunos Therapeutics’s quarterly revenue?
Alaunos Therapeutics's quarterly revenue for Q2 2024 was $4K, a 300.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1K, a 0% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). TCRT's quarterly revenue for Q4 2023 was $1K, a 100.00% increase from the previous quarter (Q3 2023), and a -90.91% decrease year-over-year (Q4 2022).
What is Alaunos Therapeutics’s revenue growth rate?
Alaunos Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -98.74%, and for the last 5 years (2019-2023) was 0%.